Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
-
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025
-
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
-
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
-
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
-
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
-
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
-
BioStem Technologies Reports Third Quarter 2025 Financial Results
-
BioStem Technologies Announces Filing of Restated Financial Statements
-
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes